Dear Valued Visitor,

We have noticed that you are using an ad blocker software.

Although advertisements on the web pages may degrade your experience, our business certainly depends on them and we can only keep providing you high-quality research based articles as long as we can display ads on our pages.

To view this article, you can disable your ad blocker and refresh this page or simply login.

We only allow registered users to use ad blockers. You can sign up for free by clicking here or you can login if you are already a member.

Ken Brodkowitz’s Newland Capital is Extremely Bullish About This Microcap Stock

Ken Brodkowitz and Michael Vermut’s Newland Capital disclosed a 6.58% stake in CTPartners Executive Search Inc (CTP). They now own 472 thousand shares of CTP and their stake is worth $6.4 Million. This purchase wasn’t very surprising though. Newland Capital had 415 thousand shares of CTP at the end of March. As the stock lost nearly 15% in 2011, Brodkowitz and Vermut decided that it is a bigger bargain.

Chuck Royce

There are other hedge funds who are bullish about CTP as well. Chuck Royce’s Royce & Associates own nearly 4% of the outstanding shares. Mark Broach’s Manatuck Hill Partners had around 1.5% of CTP’s outstanding shares at the end of March. This is a lot of hedge fund interest in a micro cap stock that has a market cap of only $98 Million. Micro cap stocks are usually less covered by Wall Street analysts and other investors. That’s why they present larger opportunities for the hedge funds which do the leg work and analyze these stocks in detail. We believe ordinary investors can benefit by following the footsteps of these hedge funds.

Ken Brodkowitz used to be an equity trader at Goldman Sachs and a portfolio manager at Rajaratnam’s Galleon. Mike Vermut was an analyst at Harvest Management. The duo met at Dmitry Balyasny’s Balyasny Asset Management and were managing an industrial-focused portfolio from 2003 to 2007. Brodkowitz and Vermut left Balyasny and launched Newland Capital, a long/short equity hedge fund, in 2007.

Biotech Stock Alert - 20% Guaranteed Return in One Year

Hedge Funds and Insiders Are Piling Into

One of 2015's best hedge funds and two insiders snapped up shares of this medical device stock recently. We believe its transformative and disruptive device will storm the $3+ billion market and help it achieve 500%-1000% gains in 3 years.

Get your FREE REPORT and the details of our 20% return guarantee today.

Subscribe me to Insider Monkey's Free Daily Newsletter
This is a FREE report from Insider Monkey. Credit Card is NOT required.
Loading Comments...

Thanks! An email with instructions is sent to !

Your email already exists in our database. Click here to go to your subscriptions

Insider Monkey returned 102% in 3 years!! Wondering How?

Download a complete edition of our newsletter for free!